Adrenomedullin

Adrenomedullin (also known as ADM) is a peptide hormone that plays a crucial role in various physiological functions. It was first discovered in 1993 in human pheochromocytoma adrenal medulla tissue, hence its name. Adrenomedullin is encoded by the ADM gene and is composed of 52 amino acids.

Structure

Adrenomedullin is a member of the calcitonin gene-related peptide family. It has a ring structure formed by a disulfide bond between two cysteine residues, and an amidated C-terminal tyrosine residue, which is essential for its biological activity.

Function

Adrenomedullin acts as a potent vasodilator, meaning it helps to widen blood vessels, which in turn lowers blood pressure. It also has anti-inflammatory properties and plays a role in the regulation of cell growth and apoptosis. Adrenomedullin is widely distributed in various tissues and organs, including the kidney, lung, and cardiovascular system.

Clinical significance

Elevated levels of adrenomedullin have been observed in several diseases, such as hypertension, heart failure, and sepsis. It is believed that the body increases production of adrenomedullin in response to these conditions as a compensatory mechanism. However, excessive adrenomedullin can also have detrimental effects, such as promoting angiogenesis in cancer.

Research

Research into the potential therapeutic uses of adrenomedullin is ongoing. Some studies suggest that it may have potential as a treatment for conditions such as pulmonary hypertension and kidney disease.

See also

• Calcitonin gene-related peptide
• Pheochromocytoma
• Vasodilation